Market Place
Sourcing Support
Repligen Acquires Bioprocessing Analytics Portfolio From 908 Devices
04 Mar 2025 //
BUSINESSWIRE
Repligen Buys Bioprocessing Analytics Portfolio From 908 Devices
04 Mar 2025 //
GLOBENEWSWIRE
Repligen Acquires 908 Devices’ Bioprocess Analytics Portfolio
04 Mar 2025 //
CONTRACTPHARMA
Repligen Reports Q4 & Full Year 2024 Financial Results
20 Feb 2025 //
GLOBENEWSWIRE
Repligen to Report Q4 & Full Year 2024 Financial Results
11 Feb 2025 //
GLOBENEWSWIRE
Repligen Corporation to Present at 43rd J.P. Morgan Conference
07 Jan 2025 //
GLOBENEWSWIRE
Repligen Launches the CTech™ SoloVPE® PLUS System
06 Jan 2025 //
GLOBENEWSWIRE
Repligen Publishes 2023 Corporate Sustainability Report
12 Dec 2024 //
GLOBENEWSWIRE
Repligen Launches AVIPure® dsRNA Resin in OPUS® Columns
09 Dec 2024 //
GLOBENEWSWIRE
Repligen Reports Q3 2024 Financial Results
12 Nov 2024 //
GLOBENEWSWIRE
Repligen Corporation to Present at Upcoming Investor Conferences
05 Nov 2024 //
GLOBENEWSWIRE
Repligen to Report Third Quarter 2024 Financial Results
31 Oct 2024 //
GLOBENEWSWIRE
Repligen Opens Training & Innovation Center to Elevate Experience
24 Sep 2024 //
GLOBENEWSWIRE
Repligen Corporation to Present at Wells Fargo Healthcare Conference
23 Aug 2024 //
GLOBENEWSWIRE
Repligen Reports Second Quarter 2024 Financial Results
30 Jul 2024 //
GLOBENEWSWIRE
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti
29 Jul 2024 //
GLOBENEWSWIRE
Repligen to Report Second Quarter 2024 Financial Results
16 Jul 2024 //
GLOBENEWSWIRE
Repligen Announces CEO Transition Plan
13 Jun 2024 //
GLOBENEWSWIRE
Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing
09 Jun 2024 //
INDIANPHARMAPOST
Repligen Corporation to Present at Upcoming June Investor Conferences
22 May 2024 //
GLOBENEWSWIRE
Repligen Corporation to Present at Upcoming May Investor Conferences
07 May 2024 //
GLOBENEWSWIRE
Repligen Reports First Quarter 2024 Financial Results
01 May 2024 //
GLOBENEWSWIRE
Repligen to Report Q1 2024 Financial Results
17 Apr 2024 //
GLOBENEWSWIRE
Repligen Appoints Maggie A. Pax to Board of Directors
19 Mar 2024 //
GLOBENEWSWIRE
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 2024 //
GLOBENEWSWIRE
Repligen to Report Fourth Quarter and Full Year 2023 Financial Results
07 Feb 2024 //
GLOBENEWSWIRE
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
19 Dec 2023 //
GLOBENEWSWIRE
Repligen Announces Convertible Transaction of $600 Million Principal Amount
07 Dec 2023 //
GLOBENEWSWIRE
UPDATE “ Repligen Announces Publication of the Company™s Sustainability Report
14 Nov 2023 //
GLOBENEWSWIRE
Repligen Corporation to Present at Upcoming Investor Conferences
07 Nov 2023 //
GLOBENEWSWIRE
Repligen Launches TangenX® SC as TFF Device
02 Nov 2023 //
GLOBENEWSWIRE
Repligen Reports Third Quarter 2023 Financial Results
31 Oct 2023 //
GLOBENEWSWIRE
Repligen to Report Third Quarter 2023 Financial Results
17 Oct 2023 //
GLOBENEWSWIRE
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
02 Oct 2023 //
GLOBENEWSWIRE
Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
26 Sep 2023 //
GLOBENEWSWIRE
Repligen Appoints Jason K. Garland as Chief Financial Officer
12 Sep 2023 //
GLOBENEWSWIRE
Repligen Corporation to Present at Wells Fargo Healthcare Conference
01 Sep 2023 //
GLOBENEWSWIRE
Sartorius and Repligen Launch Integrated System with Biostat STR and XCell ATF
17 Aug 2023 //
GLOBENEWSWIRE
Repligen Reports Second Quarter 2023 Financial Results
02 Aug 2023 //
GLOBENEWSWIRE
Repligen to Report Second Quarter 2023 Financial Results
19 Jul 2023 //
GLOBENEWSWIRE
Repligen Corporation to Present at Upcoming Investor Conferences
31 May 2023 //
GLOBENEWSWIRE
Repligen Reports 1Q 2023 FYR and Updates Full Year 2023 Financial Guidance
02 May 2023 //
GLOBENEWSWIRE
Repligen Corpo to Present at KeyBanc Life Science and MedTech Investor Forum
14 Mar 2023 //
GLOBENEWSWIRE
Repligen Reports Fourth Quarter and Full Year 2022 Financial Results
22 Feb 2023 //
GLOBENEWSWIRE
Repligen Appoints Martin D. Madaus to Board of Directors
09 Feb 2023 //
GLOBENEWSWIRE
Repligen to Report Fourth Quarter and Full Year 2022 Financial Results
08 Feb 2023 //
GLOBENEWSWIRE
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 //
GLOBENEWSWIRE
Repligen Extends and Expands Long-Term Supply Agreement with Purolite
01 Nov 2022 //
GLOBENEWSWIRE
Repligen Reports 3Q 2022 FYR and Updates Full Year 2022 Financial Guidance
01 Nov 2022 //
GLOBENEWSWIRE
Purolite Extends Partnership with Repligen
01 Nov 2022 //
CONTRACTPHARMA
Repligen Expands Process Analytics Portfolio with DRS Daylight So Agreement
19 Sep 2022 //
GLOBENEWSWIRE
Repligen To Host Investor Day 2022
24 Aug 2022 //
GLOBENEWSWIRE
Vendor identity: Catalent could enter the CDMO elite with Repligen buy
22 Aug 2022 //
BIOPROCESS INTERNATIONAL
Repligen Reports Second Quarter 2022 Financial Results
02 Aug 2022 //
GLOBENEWSWIRE
Repligen to Report Second Quarter 2022 Financial Results
19 Jul 2022 //
GLOBENEWSWIRE
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
26 May 2022 //
GLOBENEWSWIRE
Repligen Corporation to Present at Upcoming Investor Conferences
25 May 2022 //
GLOBENEWSWIRE
Repligen Reports Q1 2022 Financial Results
27 Apr 2022 //
GLOBENEWSWIRE
Repligen to Report First Quarter 2022 Financial Results
13 Apr 2022 //
GLOBENEWSWIRE
Repligen Corp to Present at KeyBanc Life Science and MedTech Investor Forum
18 Mar 2022 //
GLOBENEWSWIRE
